Lumenis Expands Product Line with a New ResurFX System


Lumenis Ltd. launched its new ResurFX™ laser system for fractional non-ablative skin resurfacting treatments. This new ResurFX system is a stand-alone desktop solution, which builds upon the successful launch of ResurFX module for the M22™ multi-application platform. The system debuted at the International Master Course on Aging Skin (IMCAS) Annual World Congress 2015.

The new ResurFX system offers advanced features to improve efficacy and patient comfort, allowing practices to expand their non-ablative treatment offering. Lumenis’ CoolScan™ technology ensures precise and safe energy delivery with continuous contact cooling, while the ResurFX system’s customized treatment parameters allow aesthetic professionals to choose from more than 600 combinations of shape, size, density, and energy delivery to customize treatments. ResurFX needs only one pass to be effective, saving practices time and protecting the patient's skin. With no disposables, the new ResurFX is also cost-effective for growing practices.

This extension in the field of skin resurfacing will allow physicians to choose the best solution for their practice:

  • A full multi application M22 platform with ResurFX, which also features the Lumenis Gold Standard IPL with OPT, Long Pulsed Nd:YAG and Q-Switched Nd:YAG.
  • A stand-alone desktop version of the ResurFX with a compact sleek design and user interface.

“We have seen such a dramatic rise in fractional non-ablative skin resurfacing because the procedure provides excellent results without the long downtime associated with other cosmetic procedures,” said Dr. Matteo Tretti Clementoni of Istituto Dermatologico Europeo. “ResurFX is the leading solution in this space because it provides the best balance of efficacy and patient convenience – some of my patients are even coming in for ResurFX treatment as a ‘lunch-time’ skin rejuvenation procedure.”

In addition to introducing the new ResurFX, Lumenis will also be participating in a lecture series for attendees at IMCAS. Lumenis CEO Tzipi Ozer-Armon will deliver a presentation about the growth in demand for aesthetic products and services in the Asia-Pacific market, particularly China.


Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free